Zhengyang Hu
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Immunology
- Topics
- Ferroptosis and cancer prognosis (21 papers)RNA modifications and cancer (15 papers)Cancer Immunotherapy and Biomarkers (12 papers)
- Journals
- SHILAP Revista de lepidopterologíaFree Radical Biology and MedicineEuropean Journal of Operational Research
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Zhengyang Hu
55 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 498
- Cancer Research 355
- Pulmonary and Respiratory Medicine 346
- Oncology 299
- Immunology 149
Countries citing papers authored by Zhengyang Hu
This map shows the geographic impact of Zhengyang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyang Hu more than expected).
Fields of papers citing papers by Zhengyang Hu
This network shows the impact of papers produced by Zhengyang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyang Hu. The network helps show where Zhengyang Hu may publish in the future.
Co-authorship network of co-authors of Zhengyang Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Zhengyang Hu. A scholar is included among the top collaborators of Zhengyang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengyang Hu. Zhengyang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 4 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 13 | |
| 9 | 14 | |
| 10 | 30 | |
| 11 | 7 | |
| 12 | 7 | |
| 13 | 6 | |
| 14 | 6 | |
| 15 | 30 | |
| 16 | 6 | |
| 17 | 7 | |
| 18 | 23 | |
| 19 | 23 | |
| 20 | 8 |
About Zhengyang Hu
Zhengyang Hu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 61 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (21 papers), RNA modifications and cancer (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Cancer Research (355 citations), Oncology (299 citations) and Pulmonary and Respiratory Medicine (346 citations). Zhengyang Hu has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Guiping Hu, Cheng Zhan, Jiaqi Liang, Zhencong Chen, Qun Wang, Ming Li, Mengnan Zhao, Yiwei Huang, Qihai Sui and Guoshu Bi. Their work appears in journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and European Journal of Operational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.